- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Myeloproliferative disorder (polycythemia vera, myelofibrosis) with poor prognostic features.
Total 256930 results
-
PharmaMarCompletedMyelofibrosisUnited States, Italy
-
The University of Hong KongRecruitingMyelofibrosis | Primary Myelofibrosis, Prefibrotic StageHong Kong
-
The Catholic University of KoreaCompletedStroke | Respiration Disorders | Aspiration Pneumonia | Swallowing Disorder | Phonation Disorder | Aspiration; LiquidsKorea, Republic of
-
Vanderbilt University Medical CenterVanderbilt Institute for Clinical and Translational ResearchCompletedNervous System Diseases | Neurologic Manifestations | Movement Disorders | Neuromuscular Manifestations | Cervical Dystonia | Focal Dystonia | Signs and Symptoms | Spasmodic TorticollisUnited States
-
Massachusetts General HospitalIncyte CorporationActive, not recruitingMyelofibrosisUnited States
-
PfizerTerminatedPrimary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia MyelofibrosisUnited States, Japan
-
Bristol-Myers SquibbRecruiting
-
Center for International Blood and Marrow Transplant...National Cancer Institute (NCI); National Institutes of Health (NIH); National...RecruitingMyelofibrosisUnited States
-
Karyopharm Therapeutics IncActive, not recruitingMyelofibrosisSpain, China, Poland, United States, France, Greece, Italy
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMyelofibrosisUnited States
-
Stichting Hemato-Oncologie voor Volwassenen NederlandCTI BioPharma; Dutch Cancer SocietyActive, not recruitingMyelofibrosisNetherlands, Belgium
-
Qilu Hospital of Shandong UniversityCompleted
-
Geron CorporationCompletedMyelofibrosisUnited States, France, Italy, United Kingdom, Belgium, Germany, Taiwan, Spain, Israel, Korea, Republic of, Canada
-
Hoffmann-La RocheCompletedMyelofibrosisItaly, United States, Canada, Germany
-
SanofiCompletedMyelofibrosisUnited States
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingSecondary MyelofibrosisUnited States
-
CelgeneCompletedMyelofibrosis | Myeloid Metaplasia | Myelofibrosis With Myeloid MetaplasiaUnited States, Italy, United Kingdom, Austria, Spain
-
Disc Medicine, IncRecruitingPrimary Myelofibrosis | Anemia | Myelofibrosis | Post-essential Thrombocythemia Myelofibrosis | Myelofibrosis; Anemia | Myelofibrosis Due to and Following Polycythemia VeraUnited States
-
Central Hospital, Nancy, FranceNot yet recruitingAlzheimer Disease | Homocystinemia
-
CelgeneRecruitingPrimary Myelofibrosis | Myeloproliferative Disorders | Anemia | Myelofibrosis | Post-Polycythemia Vera MyelofibrosisFrance, Belgium, Spain, Australia, Canada, United States, Korea, Republic of, Romania, Japan, Israel, Italy, Austria, China, Czechia, Germany, Greece, Ireland, Poland, United Kingdom, Hong Kong, Hungary, Lebanon, Argentina, Chile, Colombia and more
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Keros Therapeutics, Inc.IQVIA BiotechRecruitingMyelofibrosisAustralia
-
Karyopharm Therapeutics IncRecruitingMyelofibrosisUnited States, Korea, Republic of, Belgium, Italy, Spain, France, United Kingdom, Israel, Czechia, Taiwan, Canada, Germany, Romania, Bulgaria, Poland, Denmark
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Celgene; Incyte CorporationActive, not recruitingMyelofibrosisUnited States
-
AbbVieCompletedMyelofibrosisArgentina, Australia, Brazil, Canada, Colombia, Greece, Italy, Mexico, Poland, Portugal, Romania, Taiwan, Turkey, United States
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompleted
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompleted
-
Novartis PharmaceuticalsCompletedMyelofibrosisUnited Kingdom, Germany, Canada, Singapore, Netherlands, Italy, Australia, France
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
Weill Medical College of Cornell UniversityCompleted
-
National Taiwan University HospitalRecruitingPre-fibrotic MyelofibrosisTaiwan
-
Fred Hutchinson Cancer CenterRecruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
Imago BioSciences, Inc., a subsidiary of Merck...CompletedMyelofibrosis | Primary Myelofibrosis (PMF) | Post-polycythemia Vera Myelofibrosis (PPV-MF) | Post-essential Thrombocythemia Myelofibrosis (PET-MF)Germany, United States, Australia, Italy, United Kingdom
-
Ascentage Pharma Group Inc.WithdrawnMyelofibrosisUnited States
-
Washington University School of MedicineTakedaTerminatedMyelofibrosesUnited States
-
Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia Vera MyelofibrosisUnited States, Spain, United Kingdom, Korea, Republic of, Belgium, France, Israel, China, Japan, Italy, Germany, Taiwan, Poland, Austria, Finland, Hungary, Norway, Romania, Turkey
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States, France, Germany, Spain, Israel, Bulgaria, Romania, Japan, Taiwan, Korea, Republic of, Australia, Belgium, Canada, Netherlands, Singapore, Poland, Hungary, Denmark, Sweden, United Kingdom, Czechia, Austria
-
GlaxoSmithKlineActive, not recruitingNeoplasms | Primary Myelofibrosis (PMF) | Post-polycythemia Vera Myelofibrosis (Post-PV MF) | Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)United States, Hungary, Israel, Spain, Taiwan, France, Australia, Germany, Belgium, Canada, Singapore, Korea, Republic of, United Kingdom, Denmark, Austria, Romania, Italy, Bulgaria, Poland, Netherlands
-
Marina KremyanskayaIncyte CorporationWithdrawnMyelofibrosis | MF
-
National Cancer Institute (NCI)Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Myeloproliferative DisordersUnited States, United Kingdom, France
-
Novartis PharmaceuticalsCompletedPrimary Myelofibrosis (PMF) | Post Polycythaemia Myelofibrosis (PPV MF) | Post Essential Thrombocythaemia Myelofibrosis (PET-MF)United Kingdom
-
Geron CorporationCompletedPrimary Myelofibrosis | Secondary Myelofibrosis | Myeloid MalignanciesUnited States
-
Novartis PharmaceuticalsCompletedIdiopathic Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia-Vera MyelofibrosisUnited Kingdom, Ireland, Germany, Italy, France
-
Incyte CorporationNovartisCompletedMyelofibrosisFrance, United Kingdom, China, United States, Netherlands, Germany, Italy, Austria
-
Sumitomo Pharma America, Inc.RecruitingMyelofibrosisUnited States, Belgium, France, Japan, Australia, Italy, United Kingdom
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States, Netherlands, Austria
-
CelgeneActive, not recruiting
-
CTI BioPharmaPSI CRORecruitingPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisKorea, Republic of, Spain, Canada, Czechia, United States, Australia, France, Hungary, United Kingdom, Romania, Belarus, Bulgaria, Georgia, Germany, Israel, Italy, Poland, Russian Federation, Serbia, Ukraine, Bosnia and Herzegovina and more